Idiopathic Pulmonary Fibrosis Registry for Future Studies

Sponsor

Ohio State University (Other)

Overall Status

Completed

CT.gov ID

NCT00815711

Collaborator

(none)

Enrollment

Location

78.3

Actual Duration (Months)

0.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.

Condition or Disease	Intervention/Treatment	Phase
Lung Disease, Interstitial Idiopathic Pulmonary Fibrosis

Detailed Description

To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with physiologic measures that follow patients through their course will allow the following proposed studies as well as future investigations to be efficiently carried out.

Study Design

Study Type:

Observational

Actual Enrollment :

13 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis

Actual Study Start Date :

Dec 1, 2008

Actual Primary Completion Date :

Jun 10, 2015

Actual Study Completion Date :

Jun 10, 2015

Outcome Measures

Primary Outcome Measures

Framework [7 + years]
To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

any patient referred to the Interstitial Lund Disease clinic who is undergoing evaluation and or treatment for a new diagnosis of ILD. This can include patients referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP), sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia, drug-induced, or other idiopathic ILDs.